Showing results (281-290 of 372) with videos related to

Sort By:
Pageof 38
Neoplasia (New York, N.Y.)|January 14, 2026
Cell type composition in bulk prostate cancer tissue is a prognostic biomarkerXiaokang Zhang, Bjarne Johannessen, Susanne G Kidd, et al.
Environmental Research|December 2, 2011
Testing for bias in a sentinel species: contaminants in free-ranging domestic, wild, and hybrid minkJeff Bowman, Anne G Kidd, Pamela A Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms Tumor Study GroupM H Porteus, P Narkool, D Neuberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor StudyD M Green, N E Breslow, J B Beckwith, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 1, 1989
A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancyD M Green, G V Burton, E B Cox, et al.
Journal of Surgical Oncology|August 1, 1990
Effects of hyperthermia and irradiation on the growth of mouse melanoma tumors following immunotherapyD M Green, T V Samulski, C Vervaert, et al.
The Journal of Experimental Zoology|December 10, 1999
Protamine-like sperm nuclear basic proteins in the primitive frog Ascaphus truei and histone reversions among more advanced frogsH E Kasinsky, L Gutovich, D Kulak, et al.
Cancer|July 15, 1990
Surgery only for the treatment of patients with stage I (Cassady) Wilms' tumorE Larsen, A Perez-Atayde, D M Green, et al.
Pediatrics|January 1, 1988
Heritable fraction of unilateral Wilms tumorF P Li, W R Williams, K Gimbrere, et al.
Medical and Pediatric Oncology|January 1, 1990
Phase I study of a 120-hour continuous intravenous infusion of 5-fluorouracil in pediatric patients with recurrent solid tumors: a Pediatric Oncology Group studyD M Green, J P Krischer, B Bell, et al.
Pageof 38